Acute Effects of Alemtuzumab Infusion in Patients With Active Relapsing-Remitting MS
Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000228
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 29, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)